A drawback of using CTCs as diagnostic biomarkers is the possible lack of specificity, since they mainly use pan-cancer markers, such as the epithelial cell-adhesion molecule (EpCAM) and creatine kinase (CK) [132]. This evidence concerns the gene EPCAM and cancer.